期刊文献+

中晚期肝癌死亡原因探讨 被引量:1

Causes of Death in Patients with Advanced Hepatocellular Carcinoma
下载PDF
导出
摘要 本文报告中晚期肝癌295例,院内死亡51例,死亡率为17.3%。手术组(251)与非手术组(44)的死亡率分别为17.5%和15.9%,死亡时间分别为术后16.2天和入院后20.8天。主要死于休克,肝肾综合征、肝功能衰竭、癌破裂及上消化道大出血等,死因分别为6.8%、6.8%、6.1%6.1%和4.4%。作者建议作好术前肝功能储备的估计,以减少因出血、肝衰及感染等原因造成的死亡。 Of 295 cases of hepatocellular carcinoma treated at the authors' hospital, 51 died in hospital with a mortality rate of 17.3% (surgesy 17.5%, non-surgery 15.9%). The mean time to death was 16.2 days after surgery or 20.8 days after admission. The main causes of death included shock (6.8%), hepato-renal syndrome (6.8%), hepatic failure (6.1%), rupture of tumor mass (6.1%) and massive hemorrhage in upper GI tract (4.4%). It is suggested that the liver function should be thoroughly estimated before surgery in order to reduce the occurrence of hemorrhage, hepatic failure or infection.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1992年第3期213-215,共3页 Chinese Journal of Clinical Oncology
关键词 死亡率 死因 肝肿瘤 Hepatocellular carcinoma Causes of death
  • 相关文献

参考文献2

  • 1Edward C. S. Lai F.R.C.S.E., F.R.A.C.S., T.K. Choi, M.D.,S. W. Tong M.B., B.S.,G. B. Ong D.Sc, F.R.C.S., F.R.C.S.E., F.R.A.C.S., F.A.C.S.,John Wong Ph.D., F.R.A.C. S., F.R.C.S.E., F.A.C.S.. Treatment of unresectable hepatocellular carcinoma : Results of a randomized controlled trial[J] 1986,World Journal of Surgery(3):501~508
  • 2Hisashi Mimura M.D.,Norihisa Takakura M.D.,Yasuhiko Ohno M.D.,Tadakazu Matsuda M.D.,Hitoshi Kin M.D.,Keisuke Hamazaki M.D.,Makoto Tsumura M.D.,Satoshi Toda M.D.,Yoshio Hiraki M.D.. Determination of the extent of feasible hepatic resection from hepatic blood flow[J] 1986,World Journal of Surgery(2):302~309

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部